Fluoroquinolone Resistance Associated with Target Mutations and Active Efflux in Oropharyngeal Colonizing Isolates of Viridans Group Streptococci

Oropharyngeal samples from 60 hospitalized patients (30 fluoroquinolone [FQ]-treated and 30 non-FQ-treated patients) and 30 untreated nonhospitalized healthy control subjects yielded 20 isolates of viridans group streptococci with reduced susceptibility to FQ, mostly from the hospitalized patients....

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Guerin, François, Varon, Emmanuelle, Hoï, Annie Buu, Gutmann, Laurent, Podglajen, Isabelle
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Mechanisms of Resistance
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90040/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10898702/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.8.2197-2200.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!